Qube Research & Technologies (QRT)’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1
Closed -$1 3450
2024
Q2
$1 Hold
1
﹤0.01% 3703
2024
Q1
$1 Hold
1
﹤0.01% 4378
2023
Q4
$1 Hold
1
﹤0.01% 4271
2023
Q3
$2 Buy
+1
New +$3 ﹤0.01% 4006
2022
Q4
Sell
-31,434
Closed -$43K 2552
2022
Q3
$43K Sell
31,434
-3,859
-11% -$7.54K ﹤0.01% 2165
2022
Q2
$77K Buy
+35,293
New +$81K ﹤0.01% 2024
2020
Q3
Sell
-11,634
Closed -$115K 1744
2020
Q2
$115K Buy
+11,634
New +$107K ﹤0.01% 1495

Other funds holding CTSO

Qube Research & Technologies (QRT)'s CTSO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Cytosorbents Corp (CTSO) in Q3 2024, closing a stake of 1 share — an estimated $1 sold.

Qube Research & Technologies (QRT) first reported a position in CTSO in Q2 2020 and held it in 7 quarters. The position peaked at $115K in Q2 2020. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Cytosorbents Corp position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 Cytosorbents Corp share in Q3 2024, an estimated $1.
  • Qube Research & Technologies (QRT) first reported a position in Cytosorbents Corp in Q2 2020 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Cytosorbents Corp position peaked at $115K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.